163 related articles for article (PubMed ID: 15947943)
1. Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: an immunohistochemical study of 151 cases.
Bulut AS; Erden E; Sak SD; Doruk H; Kursun N; Dincol D
Virchows Arch; 2005 Jul; 447(1):24-30. PubMed ID: 15947943
[TBL] [Abstract][Full Text] [Related]
2. Expression of inducible nitric oxide synthase in human breast cancer depends on tumor grade.
Tschugguel W; Schneeberger C; Unfried G; Czerwenka K; Weninger W; Mildner M; Gruber DM; Sator MO; Waldhör T; Huber JC
Breast Cancer Res Treat; 1999 Jul; 56(2):145-51. PubMed ID: 10573107
[TBL] [Abstract][Full Text] [Related]
3. [Expression of inducible nitric oxide synthase mRNA in squamous cell carcinoma of tongue].
Chen WL; Zeng SG; Li HG; Huang HZ; Pan CB
Ai Zheng; 2002 Mar; 21(3):314-8. PubMed ID: 12452003
[TBL] [Abstract][Full Text] [Related]
4. Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas.
Vakkala M; Kahlos K; Lakari E; Pääkkö P; Kinnula V; Soini Y
Clin Cancer Res; 2000 Jun; 6(6):2408-16. PubMed ID: 10873093
[TBL] [Abstract][Full Text] [Related]
5. [Significance of telomerase expression in diagnosis and treatment of breast tumor].
Qiu XG; Liu YP; Pu QT; Gu QH; Han JJ
Ai Zheng; 2002 Nov; 21(11):1241-3. PubMed ID: 12526225
[TBL] [Abstract][Full Text] [Related]
6. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
[TBL] [Abstract][Full Text] [Related]
7. Endothelial cell nitric oxide synthase in peritumoral microvessels is a favorable prognostic indicator in premenopausal breast cancer patients.
Mortensen K; Holck S; Christensen IJ; Skouv J; Hougaard DM; Blom J; Larsson LI
Clin Cancer Res; 1999 May; 5(5):1093-7. PubMed ID: 10353743
[TBL] [Abstract][Full Text] [Related]
8. Telomerase expression in human breast cancer with and without lymph node metastases.
Nawaz S; Hashizumi TL; Markham NE; Shroyer AL; Shroyer KR
Am J Clin Pathol; 1997 May; 107(5):542-7. PubMed ID: 9128266
[TBL] [Abstract][Full Text] [Related]
9. Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma.
Madan R; Smolkin MB; Cocker R; Fayyad R; Oktay MH
Hum Pathol; 2006 Jan; 37(1):9-15. PubMed ID: 16360410
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
12. [Inducible nitric oxide synthase and basic fibroblast growth factor expression as prognostic factors in supraglottic squamous cell carcinoma].
Huang Z; Zeng ZY; Peng HW; Xia LP; Hou JH
Ai Zheng; 2003 Sep; 22(9):978-81. PubMed ID: 12969533
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of cytokine induced nitric oxide synthase in colorectal carcinoma.
Nozoe T; Yasuda M; Honda M; Inutsuka S; Korenaga D
Oncol Rep; 2002; 9(3):521-4. PubMed ID: 11956620
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP
Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast.
Sullu Y; Demirag GG; Yildirim A; Karagoz F; Kandemir B
Pathol Res Pract; 2011 Dec; 207(12):747-53. PubMed ID: 22030137
[TBL] [Abstract][Full Text] [Related]
16. Presence of endothelial calcium-dependent nitric oxide synthase in breast apocrine metaplasia.
Tschugguel W; Knogler W; Czerwenka K; Mildner M; Weninger W; Zeillinger R; Huber JC
Br J Cancer; 1996 Nov; 74(9):1423-6. PubMed ID: 8912539
[TBL] [Abstract][Full Text] [Related]
17. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X
Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005
[TBL] [Abstract][Full Text] [Related]
18. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.
He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY
PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605
[TBL] [Abstract][Full Text] [Related]
19. Expression of the serine protease, matriptase, in breast ductal carcinoma of Chinese women: correlation with clinicopathological parameters.
Jin JS; Cheng TF; Tsai WC; Sheu LF; Chiang H; Yu CP
Histol Histopathol; 2007 Mar; 22(3):305-9. PubMed ID: 17163404
[TBL] [Abstract][Full Text] [Related]
20. CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast.
Looi LM; Cheah PL; Zhao W; Ng MH; Yip CH
Malays J Pathol; 2006 Dec; 28(2):83-6. PubMed ID: 18376796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]